S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:ACON

Aclarion (ACON) Stock Price, News & Analysis

$0.20
-0.02 (-9.09%)
(As of 12/29/2023 ET)
Compare
Today's Range
$0.19
▼
$0.22
50-Day Range
$0.20
▼
$0.46
52-Week Range
$0.18
▼
$2.37
Volume
778,853 shs
Average Volume
3.44 million shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

ACON stock logo

About Aclarion Stock (NASDAQ:ACON)

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in Broomfield, Colorado.

ACON Stock Price History

ACON Stock News Headlines

December 30, 2023 | americanbankingnews.com
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update
November 27, 2023 | finance.yahoo.com
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
December 31, 2023 | Behind the Markets (Ad)
FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
November 9, 2023 | finance.yahoo.com
Aclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan Adoption
November 6, 2023 | markets.businessinsider.com
Aclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MD
October 25, 2023 | finance.yahoo.com
Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver
October 24, 2023 | finance.yahoo.com
Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting
October 2, 2023 | finance.yahoo.com
Aclarion Provides Updated Investor Presentation and Corporate Update
December 31, 2023 | Behind the Markets (Ad)
FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
September 8, 2023 | barrons.com
Aclarion Inc.
August 25, 2023 | finance.yahoo.com
Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report
June 14, 2023 | finance.yahoo.com
Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI
June 8, 2023 | benzinga.com
Why Aclarion Stock Is Popping Today
June 8, 2023 | msn.com
ACON Skyrockets after Presentation of Nociscan Abstract
June 8, 2023 | finance.yahoo.com
Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting
May 30, 2023 | finance.yahoo.com
Aclarion Announces New Engagement with The London Clinic and London Spine Clinic
May 23, 2023 | finance.yahoo.com
Aclarion, Inc. Announces Delayed 10-Q Filing
May 23, 2023 | finance.yahoo.com
Aclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD
May 19, 2023 | msn.com
Aclarion gets $2M debt financing
May 19, 2023 | finance.yahoo.com
Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts
May 10, 2023 | proactiveinvestors.com
Aclarion providing less invasive solution to treat lo back pain through augmented intelligence
April 28, 2023 | finance.yahoo.com
Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023
April 24, 2023 | ca.finance.yahoo.com
Aclarion, Inc. (ACON) Interactive Stock Chart - Yahoo Finance
April 24, 2023 | finance.yahoo.com
Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial
April 24, 2023 | benzinga.com
Why Aclarion Shares Are Soaring Today
April 24, 2023 | msn.com
Aclarion Surges on Promising Nociscan Data in DLBP
March 7, 2023 | finance.yahoo.com
Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor
See More Headlines
Receive ACON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/31/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/13/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ACON
CUSIP
N/A
CIK
1635077
Web
www.aclarion.com
Phone
833-275-2266
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-7,070,000.00
Net Margins
-5,433.03%
Pretax Margin
-5,431.85%
Return on Equity
-724.93%
Return on Assets
-220.64%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.15
Quick Ratio
0.15

Sales & Book Value

Annual Sales
$60,000.00
Price / Sales
29.30
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.28 per share
Price / Book
0.71

Miscellaneous

Outstanding Shares
8,790,000
Free Float
6,832,000
Market Cap
$1.76 million
Optionable
Not Optionable
Beta
1.12
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Dr. Jeffrey John Thramann M.D. (Age 58)
    Executive Chairman
    Comp: $318.75k
  • Mr. Brent Ness (Age 56)
    CEO, President & Director
    Comp: $418.75k
  • Mr. John Lorbiecki (Age 59)
    Chief Financial Officer
    Comp: $314.87k
  • Mr. Ryan Bond (Age 51)
    Chief Strategy Officer
    Comp: $219.53k

Key Competitors

View All Competitors

Insiders

View All Insider Transactions














ACON Stock Analysis - Frequently Asked Questions

How have ACON shares performed in 2023?

Aclarion's stock was trading at $0.58 on January 1st, 2023. Since then, ACON shares have decreased by 65.5% and is now trading at $0.20.
View the best growth stocks for 2023 here.

When is Aclarion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our ACON earnings forecast.

How were Aclarion's earnings last quarter?

Aclarion, Inc. (NASDAQ:ACON) issued its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.12) earnings per share for the quarter. The company had revenue of $0.02 million for the quarter. Aclarion had a negative net margin of 5,433.03% and a negative trailing twelve-month return on equity of 724.93%.

When did Aclarion IPO?

(ACON) raised $12 million in an IPO on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share.

How do I buy shares of Aclarion?

Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ACON) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -